166 related articles for article (PubMed ID: 14621899)
1. Expression of human decay accelerating factor or membrane cofactor protein genes on mouse cells inhibits lysis by human complement.
White DJ; Oglesby T; Liszewski MK; Tedja I; Hourcade D; Wang MW; Wright L; Wallwork J; Atkinson JP
Transpl Int; 1992; 5 Suppl 1():S648-50. PubMed ID: 14621899
[TBL] [Abstract][Full Text] [Related]
2. Protection of xenogeneic cells from human complement-mediated lysis by the expression of human DAF, CD59 and MCP.
Huang J; Gou D; Zhen C; Jiang D; Mao X; Li W; Chen S; Cai C
FEMS Immunol Med Microbiol; 2001 Oct; 31(3):203-9. PubMed ID: 11720816
[TBL] [Abstract][Full Text] [Related]
3. The control of hyperacute rejection by genetic engineering of the donor species.
White DJ; Cozzi E; Langford G; Oglesby T; Wang MW; Wright L; Wallwork J
Eye (Lond); 1995; 9 ( Pt 2)():185-9. PubMed ID: 7556715
[TBL] [Abstract][Full Text] [Related]
4. Expression of human decay accelerating factor or membrane cofactor protein genes on mouse cells inhibits lysis by human complement.
White DJ; Oglesby T; Liszewski MK; Tedja I; Hourcade D; Wang MW; Wright L; Wallwork J; Atkinson JP
Transplant Proc; 1992 Apr; 24(2):474-6. PubMed ID: 1373541
[No Abstract] [Full Text] [Related]
5. Phospholipid-anchored and transmembrane versions of either decay-accelerating factor or membrane cofactor protein show equal efficiency in protection from complement-mediated cell damage.
Lublin DM; Coyne KE
J Exp Med; 1991 Jul; 174(1):35-44. PubMed ID: 1711565
[TBL] [Abstract][Full Text] [Related]
6. Presence of human chromosome 1 with expression of human decay-accelerating factor (DAF) prevents lysis of mouse/human hybrid cells by human complement.
Wang MW; Wright LJ; Sims MJ; White DJ
Scand J Immunol; 1991 Dec; 34(6):771-8. PubMed ID: 1721235
[TBL] [Abstract][Full Text] [Related]
7. An in vivo model of hyperacute rejection: characterization and evaluation of the effect of transgenic human complement inhibitors.
Mora M; Lazzer M; Marsicano G; Mulder LC; Carraresi L; Pieri A; Benanchi A; Grifoni D; Nuti S; Bruzzone P; Comporti M; Cortesini R; Rossini M
Transgenic Res; 2000 Jun; 9(3):205-13. PubMed ID: 11032369
[TBL] [Abstract][Full Text] [Related]
8. Mouse complement regulatory protein Crry/p65 uses the specific mechanisms of both human decay-accelerating factor and membrane cofactor protein.
Kim YU; Kinoshita T; Molina H; Hourcade D; Seya T; Wagner LM; Holers VM
J Exp Med; 1995 Jan; 181(1):151-9. PubMed ID: 7528766
[TBL] [Abstract][Full Text] [Related]
9. Human lung cancer cell lines express cell membrane complement inhibitory proteins and are extremely resistant to complement-mediated lysis; a comparison with normal human respiratory epithelium in vitro, and an insight into mechanism(s) of resistance.
Varsano S; Rashkovsky L; Shapiro H; Ophir D; Mark-Bentankur T
Clin Exp Immunol; 1998 Aug; 113(2):173-82. PubMed ID: 9717965
[TBL] [Abstract][Full Text] [Related]
10. Combination of decay-accelerating factor expression and alpha1,3-galactosyltransferase knockout affords added protection from human complement-mediated injury.
van Denderen BJ; Salvaris E; Romanella M; Aminian A; Katerelos M; Tange MJ; Pearse MJ; d'Apice AJ
Transplantation; 1997 Sep; 64(6):882-8. PubMed ID: 9326415
[TBL] [Abstract][Full Text] [Related]
11. Expression of complement regulatory proteins on islets of Langerhans: a comparison between human islets and islets isolated from normal and hDAF transgenic pigs.
Bennet W; Björkland A; Sundberg B; Brandhorst D; Brendel MD; Richards A; White DJ; Nilsson B; Groth CG; Korsgren O
Transplantation; 2001 Jul; 72(2):312-9. PubMed ID: 11477359
[TBL] [Abstract][Full Text] [Related]
12. Transgenic expression in pig hearts of both human decay-accelerating factor and human membrane cofactor protein does not provide an additional benefit to that of human decay-accelerating factor alone in pig-to-baboon xenotransplantation.
Mañez R; Lopez-Pelaez E; Centeno A; Herrera JM; Juffe A; Domenech N; Harrison R; Schuurman HJ
Transplantation; 2004 Sep; 78(6):930-3. PubMed ID: 15385816
[TBL] [Abstract][Full Text] [Related]
13. C5b-8 step lysis of swine endothelial cells by human complement and functional feature of transfected CD59.
Miyagawa S; Mikata S; Shirakura R; Matsuda H; Nagasawa S; Terados A; Hatanaka M; Matsumoto M; Seya T
Scand J Immunol; 1996 Apr; 43(4):361-6. PubMed ID: 8668913
[TBL] [Abstract][Full Text] [Related]
14. Production of transgenic pigs expressing human DAF (CD55) regulated by the porcine MCP gene promoter.
Murakami H; Nagashima H; Takahagi Y; Fujimura T; Miyagawa S; Okabe M; Seya T; Shigehisa T; Taniguchi N; Shirakura R; Kinoshita T
Transplant Proc; 2000 Nov; 32(7):2505-6. PubMed ID: 11120269
[No Abstract] [Full Text] [Related]
15. Engineering of recombinant soluble CD46: an inhibitor of complement activation.
Christiansen D; Milland J; Thorley BR; McKenzie IF; Mottram PL; Purcell LJ; Loveland BE
Immunology; 1996 Mar; 87(3):348-54. PubMed ID: 8778018
[TBL] [Abstract][Full Text] [Related]
16. Adenovirus-mediated gene transfer of triple human complement regulating proteins (DAF, MCP and CD59) in the xenogeneic porcine-to-human transplantation model. Part I: in vitro assays using porcine aortic endothelial cells.
Nagahama M; Shiraishi M; Oshiro T; Taira K; Sugawa H; Nozato E; Nomura H; Nagamine M; Muto Y
Transpl Int; 2002 May; 15(5):205-11. PubMed ID: 12012040
[TBL] [Abstract][Full Text] [Related]
17. Cooperation between decay-accelerating factor and membrane cofactor protein in protecting cells from autologous complement attack.
Brodbeck WG; Mold C; Atkinson JP; Medof ME
J Immunol; 2000 Oct; 165(7):3999-4006. PubMed ID: 11034410
[TBL] [Abstract][Full Text] [Related]
18. Different membrane cofactor protein (CD46) isoforms protect transfected cells against antibody and complement mediated lysis.
Loveland BE; Johnstone RW; Russell SM; Thorley BR; McKenzie IF
Transpl Immunol; 1993; 1(2):101-8. PubMed ID: 8081768
[TBL] [Abstract][Full Text] [Related]
19. Membrane cofactor protein (CD46) protects cells from complement-mediated attack by an intrinsic mechanism.
Oglesby TJ; Allen CJ; Liszewski MK; White DJ; Atkinson JP
J Exp Med; 1992 Jun; 175(6):1547-51. PubMed ID: 1588280
[TBL] [Abstract][Full Text] [Related]
20. Molecular remodelling of human CD46 for xenotransplantation: designing a potent complement regulator without measles virus receptor activity.
Begum NA; Murakami Y; Mikata S; Matsumoto M; Hatanaka M; Nagasawa S; Kinoshita T; Seya T
Immunology; 2000 May; 100(1):131-9. PubMed ID: 10809968
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
